Dabigatran etexilate

Details

Files
Generic Name:
Dabigatran etexilate
Project Status:
Complete
Therapeutic Area:
Atrial fibrillation prevention of stroke and systemic embolism
Manufacturer:
Boehringer Ingelheim
Call for patient/clinician input open:
Brand Name:
Pradaxa
Project Line:
Reimbursement Review
Project Number:
SR0214-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Atrial fibrillation prevention of stroke and systemic embolism
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: